These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 18939944)

  • 1. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
    Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
    Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of apoptosis catch ubiquitin.
    Rajalingam K; Dikic I
    Biochem J; 2009 Jan; 417(1):e1-3. PubMed ID: 19061481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
    de Almagro MC; Goncharov T; Newton K; Vucic D
    Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.
    Varfolomeev E; Goncharov T; Fedorova AV; Dynek JN; Zobel K; Deshayes K; Fairbrother WJ; Vucic D
    J Biol Chem; 2008 Sep; 283(36):24295-9. PubMed ID: 18621737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
    Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
    ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
    Furusu A; Nakayama K; Xu Q; Konta T; Kitamura M
    J Cell Physiol; 2007 Mar; 210(3):703-10. PubMed ID: 17133355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
    Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
    Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1).
    Lee S; Challa-Malladi M; Bratton SB; Wright CW
    J Biol Chem; 2014 Oct; 289(44):30680-30689. PubMed ID: 25246529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.
    Li X; Yang Y; Ashwell JD
    Nature; 2002 Mar; 416(6878):345-7. PubMed ID: 11907583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.
    Yang QH; Du C
    J Biol Chem; 2004 Apr; 279(17):16963-70. PubMed ID: 14960576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro.
    Park SM; Yoon JB; Lee TH
    FEBS Lett; 2004 May; 566(1-3):151-6. PubMed ID: 15147886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoblot Analysis of the Regulation of TNF Receptor Family-Induced NF-κB Signaling by c-IAP Proteins.
    Varfolomeev E; Goncharov T; Vucic D
    Methods Mol Biol; 2021; 2366():109-123. PubMed ID: 34236635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of c-IAP proteins in TNF receptor family activation of NF-κB signaling.
    Varfolomeev E; Goncharov T; Vucic D
    Methods Mol Biol; 2015; 1280():269-82. PubMed ID: 25736754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling.
    Dynek JN; Goncharov T; Dueber EC; Fedorova AV; Izrael-Tomasevic A; Phu L; Helgason E; Fairbrother WJ; Deshayes K; Kirkpatrick DS; Vucic D
    EMBO J; 2010 Dec; 29(24):4198-209. PubMed ID: 21113135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
    Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
    J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
    Gyrd-Hansen M; Darding M; Miasari M; Santoro MM; Zender L; Xue W; Tenev T; da Fonseca PC; Zvelebil M; Bujnicki JM; Lowe S; Silke J; Meier P
    Nat Cell Biol; 2008 Nov; 10(11):1309-17. PubMed ID: 18931663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
    Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OTUB1 modulates c-IAP1 stability to regulate signalling pathways.
    Goncharov T; Niessen K; de Almagro MC; Izrael-Tomasevic A; Fedorova AV; Varfolomeev E; Arnott D; Deshayes K; Kirkpatrick DS; Vucic D
    EMBO J; 2013 Apr; 32(8):1103-14. PubMed ID: 23524849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.